We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.46B
AUM Growth
-$34.2M
(-1.4%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-4.63%
Top 10 Holdings %
Top 10 Hldgs %
7.2%
Holding
2,015
New
556
Increased
372
Reduced
436
Closed
645
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$17.3M |
| 2 |
Walt Disney
DIS
|
+$17.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$16M |
| 4 |
Nektar Therapeutics
NKTR
|
+$15M |
| 5 |
Halliburton
HAL
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$24.9M |
| 2 |
Boeing
BA
|
+$23.2M |
| 3 |
Electronic Arts
EA
|
+$20M |
| 4 |
Five Below
FIVE
|
+$19.6M |
| 5 |
Avis
CAR
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.32% |
| 2 | Industrials | 13.59% |
| 3 | Technology | 11.91% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLND
526
DELISTED
Talend S.A. American Depositary Shares
TLND
| $1.26M | 0.05% |
+20,177
| New | +$1.1M |
|
527
Sanmina
SANM
$9.09B
| $1.25M | 0.05% |
42,701
+29,700
| +228% | +$873K |
|
528
Ichor Holdings
ICHR
$2.39B
| $1.25M | 0.05% |
+58,922
| New | +$1.41M |
|
529
Franco-Nevada
FNV
$41B
| $1.25M | 0.05% |
+17,100
| New | +$1.21M |
|
530
Intuitive Surgical
ISRG
$130B
| $1.24M | 0.05% |
7,770
-38,100
| -83% | -$5.81M |
|
|
TAST
531
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.24M | 0.05% |
+83,500
| New | +$1.01M |
|
|
VSM
532
DELISTED
Versum Materials, Inc.
VSM
| $1.24M | 0.05% |
33,286
-16,700
| -33% | -$637K |
|
|
CRC
533
DELISTED
California Resources Corporation
CRC
| $1.24M | 0.05% |
27,212
-96,400
| -78% | -$3.05M |
|
534
Mesa Laboratories
MLAB
$552M
| $1.23M | 0.05% |
+5,838
| New | +$1.02M |
|
|
MDC
535
DELISTED
M.D.C. Holdings, Inc.
MDC
| $1.23M | 0.05% |
46,604
-44,556
| -49% | -$1.16M |
|
536
Adeia
ADEA
$2.73B
| $1.23M | 0.05% |
288,384
-134,568
| -32% | -$726K |
|
537
Atkore
ATKR
$2.59B
| $1.23M | 0.05% |
59,155
+4,100
| +7% | +$83.1K |
|
|
FCB
538
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.23M | 0.05% |
+20,900
| New | +$1.23M |
|
|
MCRN
539
DELISTED
Milacron Holdings Corp.
MCRN
| $1.23M | 0.05% |
64,803
+17,500
| +37% | +$345K |
|
540
Heron Therapeutics
HRTX
$90.8M
| $1.23M | 0.05% |
+31,534
| New | +$1M |
|
541
Stratasys
SSYS
$696M
| $1.23M | 0.05% |
+64,025
| New | +$1.26M |
|
542
Steris
STE
$22.2B
| $1.23M | 0.05% |
11,670
-3,800
| -25% | -$382K |
|
|
CUTR
543
DELISTED
Cutera, Inc.
CUTR
| $1.23M | 0.05% |
30,407
+21,500
| +241% | +$990K |
|
544
Quest Diagnostics
DGX
$26.1B
| $1.22M | 0.05% |
11,100
-10,200
| -48% | -$1.06M |
|
545
Hilton Worldwide
HLT
$72.9B
| $1.22M | 0.05% |
+15,401
| New | +$1.25M |
|
546
Fair Isaac
FICO
$32.1B
| $1.22M | 0.05% |
6,305
-1,000
| -14% | -$181K |
|
547
Medpace
MEDP
$16.3B
| $1.22M | 0.05% |
+28,330
| New | +$1.14M |
|
548
Semtech
SMTC
$10.5B
| $1.22M | 0.05% |
25,900
+9,500
| +58% | +$426K |
|
549
First Citizens BancShares
FCNCA
$24.9B
| $1.21M | 0.05% |
2,998
+1,900
| +173% | +$818K |
|
550
Rigel Pharmaceuticals
RIGL
$690M
| $1.21M | 0.05% |
42,736
+35,156
| +464% | +$1.25M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, A.R.T. Advisors held 2,015 positions worth $2.46B, down 1.4% from $2.49B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
A.R.T. Advisors withdrew a net $114M in Q2 2018, closing 645 positions and reducing 436 holdings. Its most notable exit was Five Below, an estimated $19.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.
Against the trend, A.R.T. Advisors opened a new position in Celgene Corp worth $16.6M.
- A.R.T. Advisors's largest Q2 2018 buy was Celgene Corp: 208,600 shares worth $16.6M.
- A.R.T. Advisors added most to Walt Disney in Q2 2018, an estimated $17.3M increase.
- A.R.T. Advisors's biggest Q2 2018 reduction was Ulta Beauty, cutting an estimated $24.9M.
- A.R.T. Advisors fully exited Five Below in Q2 2018, selling an estimated $19.6M.
- A.R.T. Advisors's ten largest holdings make up 7.2% of its $2.46B portfolio in Q2 2018.
- A.R.T. Advisors opened 556 new positions and closed 645 in Q2 2018.
- A.R.T. Advisors's portfolio value fell 1.4% quarter-over-quarter to $2.46B.
Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.